Neuro-ophthalmology is a specialized area of medicine that focuses on the diagnosis, treatment, and management of disease processes that involve the eye and the nervous system. Neuro-ophthalmologic disorders can affect any individual with any age, gender, ethnic background, or social class. At the clinical level, neuro-ophthalmology deals with conditions such as double vision, eyelid twitching, and vision loss. It diagnoses and manages disorders of the metabolism, inflammation, myopia, glaucoma, and tumors that can affect vision. Neuro-ophthalmologic patients may experience sudden or gradual changes in vision, eye movement, and eyelid function. Neuro-ophthalmology also includes treatment of the eye's anterior structures, such as the cornea, lens, iris, and pupil. In a basic science perspective, neuro-ophthalmology is an interdisciplinary field that combines neuroscience and ophthalmology. Neuro-ophthalmology focuses on the neural pathways that coordinate visual reflexes, muscle control, and vision. Scientists in this field have studied how the nervous system processes vision and controls eye movements. In addition, neuro-ophthalmologists study conditions such as oculomotor dysfunction, accommodative spasm, and diplopia. Furthermore, research in the field of neuro-ophthalmology has helped to develop treatments for diseases that affect eye health, such as glaucoma and macular degeneration. Additionally, neuro-ophthalmology includes research in the molecular basis of vision, as well as how our brains recognize and interpret visual information. Neuro-ophthalmology is an interdisciplinary field that applies clinical and basic science principles to the diagnosis and management of disorders affecting the eye and vision. Through research, neuro-ophthalmologists have developed treatments and therapies that can help improve the vision and quality of life for individuals affected by neuro-ophthalmologic disorders.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States